±¹¸³¾Ï¼¾ÅÍ, ´ëÇѾÏÇÐȸ 5°³ Çмú»ó µ¿½Ã ¼ö»ó

´º½ºÀÏÀÚ: 2018³â06¿ù25ÀÏ 11½Ã42ºÐ

[º¸°ÇŸÀÓÁî] ±¹¸³¾Ï¼¾ÅÍ(¿øÀå ÀÌÀº¼÷)´Â Áö³­ 6¿ù 22ÀÏ(±Ý) ¼­¿ï·Ôµ¥È£ÅÚ¿¡¼­ °³ÃֵȑÁ¦44Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× ±¹Á¦¾ÏÄÁÆÛ·±½º’¿¡¼­ ÃÑ 5°³ÀÇ Çмú»óÀ» µ¿½Ã ¼ö»óÇß´Ù.(»çÁø, Á÷Ã¥»ý·«) 

ÀÌÀº¼÷

°ø¼±¿µ

¿ø¿µÁÖ

¹ÚÀÎÇý

Ãֱͼ±

ÀÌÀº°æ

ÀÌÀº¼÷ ¿øÀå ¹× °ø¼±¿µ ´ë¿ÜÇù·Â½ÇÀå/Áø´Ü°Ë»çÀÇÇаúÀåÀº ‘Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes among Korean Breast Cancer Patients’·Î, ¿ø¿µÁÖ Á߾Ӿϵî·Ï»ç¾÷ºÎÀåÀº ‘Lung Cancer Epidemiology in Korea’·Î, ¹ÚÀÎÇý ¾ÏÁß°³¿¬±¸°úÀåÀº ‘An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer’ ³í¹®À¸·Î °¢°¢ ·Î½´¾ÏÇмú»óÀ» ¼ö»óÇß´Ù.

¶Ç, Ãֱͼ± ±¹Á¦¾Ï´ëÇпø´ëÇб³ ±³¼ö´Â ‘Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality’·Î, ÀÌÀº°æ °©»ó¼±¾Ï¼¾ÅÍ Àü¹®ÀÇ´Â ‘Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer’·Î °¢°¢ ±¤µ¿¾ÏÇмú»óÀ» ¼ö»óÇß´Ù.

´ëÇѾÏÇÐȸÁö´Â 1973³â ´ëÇѾϿ¬±¸È¸ ÀâÁö¸¦ ½ÃÀÛÀ¸·Î Áö¼ÓÀûÀ¸·Î ¹ß°£µÇ¾î ÇöÀç SCIE¿¡ µîÀçµÇ´Â ±¹Á¦ÀûÀÎ ¿µ¹®ÇмúÁöÀÎ ‘Cancer Research and Treatment’·Î ¹ß°£µÇ°í ÀÖ´Ù. ´ëÇѾÏÇÐȸ´Â Çмú´ëȸ ±â°£¿¡ Áö³­ 1³â µ¿¾È ´ëÇѾÏÇÐȸÁö¿¡ ¹ßÇ¥µÈ ³í¹® Áß ¿ì¼ö ³í¹®À» ¼±Á¤ÇØ »óÀ» ¼ö¿©ÇÏ°í ÀÖ´Ù.


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.